Skip to content

Effect of Brahmi Avleha and Brahmi Taila Nasya in Attention Deficit Hyperactivity Disorder in children

To evaluate the efficacy of Brahmi Avleha along with Brahmi Taila Pratimarsh Nasya in the management of Attention Deficit / Hyperactivity Disorder in children

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053855
Enrollment
76
Registered
2023-06-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type

Interventions

None listed

Sponsors

Post Graduate Institute of Ayurveda, Jodhpur, Rajasthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individual between age group of 6 to 15 years of both sexes 2. Individual satisfying Vanderbilt Assessment scale 3. Individual having borderline or more IQ will be considered

Exclusion criteria

Exclusion criteria: 1. Individual below 6 year & above 15 years of age. 2. Mental disorders like conduct disorder, anxiety, depressive disorders, obsessive disorders & compulsive disorder. 3. Children with schizophrenia. 4. Children having medical illness like hearing loss, hypothyroidism, genetic disorder & seizures disorder. 5. Children having congenital deformity or Muscular dystrophy. 6. Children suffering from any severe or acute infections.

Design outcomes

Primary

MeasureTime frame
To evaluate the clinical efficacy of Brahmi Avleha along with Brahmi Taila Pratimarsh Nasya in the management of Attention â?? Deficit / Hyperactivity Disorder in 76 children.Timepoint: 45 days

Secondary

MeasureTime frame
To improve school performance & health status of childrenTimepoint: 45 days

Countries

India

Contacts

Public ContactDr Harish Kumar Singhal

Post Graduate Institute of Ayurveda

khandelwalrani93@gmail.com8824262959

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026